| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10036751 | HBV | ENSG00000136160.17 | protein_coding | EDNRB | No | No | 1910 | P24530 |
| TVIS10050050 | HBV | ENSG00000136160.17 | protein_coding | EDNRB | No | No | 1910 | P24530 |
| TVIS30035474 | HIV | ENSG00000136160.17 | protein_coding | EDNRB | No | No | 1910 | P24530 |
| TVIS20046672 | HPV | ENSG00000136160.17 | protein_coding | EDNRB | No | No | 1910 | P24530 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | EDNRB |
|---|---|
| DrugBank ID | DB06558 |
| Drug Name | Tezosentan |
| Target ID | BE0000043 |
| UniProt ID | P24530 |
| Regulation Type | |
| PubMed IDs | 15542526 |
| Citations | Urbanowicz W, Sogni P, Moreau R, Tazi KA, Barriere E, Poirel O, Martin A, Guimont MC, Cazals-Hatem D, Lebrec D: Tezosentan, an endothelin receptor antagonist, limits liver injury in endotoxin challenged cirrhotic rats. Gut. 2004 Dec;53(12):1844-9. |
| Groups | Investigational |
| Direct Classification | Pyridinylpyrimidines |
| SMILES | COC1=CC=CC=C1OC1=C(NS(=O)(=O)C2=NC=C(C=C2)C(C)C)N=C(N=C1OCCO)C1=CC(=NC=C1)C1=NNN=N1 |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL61780 |
